Overexpression of vasostatin-1 protects hypoxia/reoxygenation injuries in cardiomyocytes-endothelial cells transwell co-culture system

Cell Biology International

Volumn 38, Issue 1, 2014, Pages 26-31

  Liu, Jian ^a   Yang, Dicheng ^a   Shi, Sheng ^a   Lin, Lei ^a   Xiao, Mingdi ^a   Yuan, Zhongxiang ^a   Yu, Min ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Cardiomyocytes; Endothelial cells; Hypoxia; Myocardial damage; Transwell co culture system; Vasostatin 1

Indexed keywords

ADENOVIRUS VECTOR; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; PROTECTIVE AGENT; UNCLASSIFIED DRUG; VASOSTATIN 1;

ABDOMINAL AORTA; ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL INTERACTION; COCULTURE; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NEWBORN; NONHUMAN; RAT; REPERFUSION INJURY; VIRAL GENE DELIVERY SYSTEM; VS 1 GENE;

RATTUS;

CARDIOMYOCYTES; ENDOTHELIAL CELLS; HYPOXIA; MYOCARDIAL DAMAGE; TRANSWELL CO-CULTURE SYSTEM; VASOSTATIN-1;

ANIMALS; AORTA; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CATTLE; CELL HYPOXIA; CELLS, CULTURED; CHROMOGRANIN A; COCULTURE TECHNIQUES; CREATINE KINASE, MB FORM; ENDOTHELIAL CELLS; GENE EXPRESSION; HEMOGLOBINS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFECTION;

EID: 84892976087     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10166     Document Type: Article

References (27)

1. Akedo H, Shinkai K, Mukai M, Mori Y, Tateishi R, Tanaka K, Yamamoto R, Morishita T (1986) Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res 46: 2416-22.
2. Blois A, Srebro B, MandalàM, Corti A, Helle KB, Serck-Hanssen G (2006) The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells. Regul Pept 135: 78-84.
3. Brekke JF, Osol GJ, Helle KB (2002) N-Terminal chromograninderived peptides as dilators of bovine coronary resistance arteries. Regul Pept 105: 93-100.
4. Cappello S, Angelone T, Tota B, Pagliaro P, Penna C, Rastaldo R, Corti A, Losano G, Cerra MC (2007) Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. Sci Signal 293: H719.
5. Cerra MC, De Iuri L, Angelone T, Corti A, Tota B (2006) Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res Cardiol 101: 43-52.
6. Cerra M, Gallo M, Angelone T, Quintieri A, Pulerà E, Filice E, Guérold B, Shooshtarizadeh P, Levi R, Ramella R (2008) The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. FASEB J 22: 3992-4004.
7. del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, Gwathmey JK, Hajjar RJ (2004) Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci USA 101: 5622-7.
8. Fornero S, Bassino EP, Gallo M, Ramella R, Levi R, Alloatti G (2012) Endothelium dependent cardiovascular effects of the chromogranin A-derived peptides vasostatin-1 and catestatin. Curr Med Chem 19: 4059-67.
9. Francis CK, Kuo YH, Azzam I, Selim S, Patel N, Beri R, Goldman D, Girgis I, Daniels S (2012) Brain natriuretic peptide and biomarkers of myocardial ischemia increase after defibrillation threshold testing. Pacing Clin Electrophysiol 35: 314-319.
10. Gallo MP, Levi R, Ramella R, Brero A, Boero O, Tota B, Alloatti G (2007) Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium. Am J Physiol Heart Circ Physiol 292: H2906-H2912.
11. Helle KB (2010) The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions. Cardiovasc Res 85: 9-16.
12. Huang CP, Lu J, Seon H, Lee AP, Flanagan LA, Kim H-Y, Putnam AJ, Jeon NL (2009) Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 9: 1740-8.
13. Kuramochi Y, Cote GM, Guo X, Lebrasseur NK, Cui L, Liao R, Sawyer DB (2004) Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1b/erbB4 signaling. J Biol Chem 279: 51141-7.
14. Li Y-H, Zhu C (1999) A modified Boyden chamber assay for tumor cell transendothelial migration in vitro. Clin Exp Metastasis 17: 423-9.
15. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, Hawkins SM, Clowes AW (1999) Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85: 1179-85.
16. Moens A, Claeys MJ, Timmermans J-P, Vrints C (2005)Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100: 179-90.
17. Pagliaro P, Cappello S, Rastaldo R, Penna C, Angelone T, Corti A, Tota B, Losano G (2007) Protection against ischemia/reperfusion injures by vasostatin-1 in the isolated rat heart. Comp Biochem Physiol A Mol Integr Physiol 147: 23-4.
18. PrabodhV, PrakashD, Sudhakar G, Reddy Y, ChowdaryN, Desai S, Shekhara R (2012) Importance of cardiac marker enzymes (aspartate transaminase and troponin I) in acute myocardial infarction: a case-control study from South India. Int J Med Sci Public Health 1: 118-20.
19. Tota B, Quintieri AM, Di Felice V, CerraMC(2007)New biological aspects of chromogranin A-derived peptides: focus on vasostatins. Comp Biochem Physiol AMol Integr Physiol 147: 11-8.
20. Turer AT, Hill JA (2010) Pathogenesis of myocardial ischemiareperfusion injury and rationale for therapy. Am J Cardiol 106: 360-8.
21. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL (1998) Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97: 2259-67.
22. Veschini L, Crippa L, Dondossola E, Doglioni C, Corti A, Ferrero E (2011) The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization. FASEB J 25: 3906-14.
23. Wildhirt SM, Weismueller S, Schulze C, Conrad N, Kornberg A, Reichart B (1999) Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res 43: 698-711.
24. Yang YI, Kim JH, Lee KT, Choi JH (2011) Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species. Gynecol Oncol 123: 588-96.
25. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357: 1121-35.
26. Yu M,Wang Z, Fang Y, Xiao MD, Yuan ZX, Lu CB, Lin L, Yang DC (2011) Overexpression of vasostatin-1 protects hypoxia/reoxygenation injuries in cardiomyocytes independent of endothelial cells. Cardiovasc Ther 30: 145-51.
27. Zhang Z, McGoron A, Crumpler E, Li C-Z (2011) Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study. Appl Biochem Biotechnol 163: 278-95.